Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
NCT ID: NCT05056350
Last Updated: 2025-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
25 participants
INTERVENTIONAL
2021-09-13
2027-08-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients.
This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer
NCT04469205
Psychosocial Support to Facilitate the Return to Employment of Women With Breast Cancer
NCT01780064
Life After Breast Cancer - Impact of a Life Coach
NCT05020561
ACTIVPROSEIN : Professional Activity After Breast Cancer
NCT06025604
Realistic Evaluation of a Job Retention Program After Breast Cancer
NCT05919498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to evaluate the feasibility of a support program for an adapted return to work of these patients.
This back-to-work support program including an individual interview to identify patient needs and expectations, 7 coaching workshops (every 3 weeks +/- 15 days) and a final individual assessment post workshops.
The evolution of quality of life, psychological distress and perceptions concerning work will also be evaluated through assessments and questionnaires before (inclusion) and after the support program \[1 month (+/- 7 days) and 6 months (+/- 1 month) after the final individual assessment\].
The study also aims to estimate the recruitment rate in the study and to assess the satisfaction of this support program.
Finally, the impact of this support program on the return to work will be described.
This initial study will eventually lead to a larger research protocol on the effectiveness of the program, using a randomized controlled trial design.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Assessment of the feasibility and impact of a back-to-work support program
questionnaires, back to work coaching
Questionnaires
Quality of life questionnaires, work perception questionnaires, psychological distress questionnaire
back to work coaching
Back-to-work support program including an individual interview to identify patient needs and expectations, 7 coaching workshops (every 3 weeks +/- 15 days) and a final individual assessment post workshops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
Quality of life questionnaires, work perception questionnaires, psychological distress questionnaire
back to work coaching
Back-to-work support program including an individual interview to identify patient needs and expectations, 7 coaching workshops (every 3 weeks +/- 15 days) and a final individual assessment post workshops
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy)
* Patient who has completed adjuvant treatment, except for hormonotherapy
* Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis
* Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field
* Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job
* Patient who signed the informed consent after informed information by her clinician
Exclusion Criteria
* Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy)
* Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder (American Psychiatric Association, 1994) Sheehan et al., 1998) with the patient's refusal of adequate psychiatric treatment (medicated or not) at the time of inclusion in the study
* Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test)
* Physical inability to answer questionnaires
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut du Cancer de Montpellier - Val d'Aurelle
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Estelle Guerdoux, Dr
Role: STUDY_CHAIR
Institut du Cancer de Montpellier - Val d'Aurelle
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut du Cancer de Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Arfi A, Baffert S, Soilly AL, Huchon C, Reyal F, Asselain B, Neffati S, Rouzier R, Hequet D. Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study. BMJ Open. 2018 May 18;8(5):e020276. doi: 10.1136/bmjopen-2017-020276.
Banning M. Employment and breast cancer: a meta-ethnography. Eur J Cancer Care (Engl). 2011 Nov;20(6):708-19. doi: 10.1111/j.1365-2354.2011.01291.x. Epub 2011 Sep 20.
Barnes AJ, Robert N, Bradley CJ. Job attributes, job satisfaction and the return to health after breast cancer diagnosis and treatment. Psychooncology. 2014 Feb;23(2):158-64. doi: 10.1002/pon.3385. Epub 2013 Sep 3.
de Boer AG, Verbeek JH, Spelten ER, Uitterhoeve AL, Ansink AC, de Reijke TM, Kammeijer M, Sprangers MA, van Dijk FJ. Work ability and return-to-work in cancer patients. Br J Cancer. 2008 Apr 22;98(8):1342-7. doi: 10.1038/sj.bjc.6604302. Epub 2008 Mar 18.
Ekbladh E, Thorell LH, Haglund L. Perceptions of the work environment among people with experience of long term sick leave. Work. 2010;35(2):125-36. doi: 10.3233/WOR-2010-0964.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A00955-34
Identifier Type: OTHER
Identifier Source: secondary_id
PROICM 2020-07 VIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.